UTILISATION DE L'HORMONE DE CROISSANCE A FAIBLE DOSE
European patent · EP1265629 · Deleted
Register entry
- Publication number
- EP1265629
- Application number
- EP01914289
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Mar 13, 2001
- Published
- Dec 18, 2002
- Granted
- Jun 7, 2006
- Deleted
- Mar 31, 2009
- Reason
- Annual fee unpaid
- IPC classes
- A61K 38/27 (2006.01)//A61P 3/10 (2006.01)
- Priority
- SE 0000837 13.03.2000
- PCT application
- PCT/SE2001/000522 13.03.2001
- PCT publication
- WO2001/068127 20.09.2001
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 21, 2009
Deleted, fee unpaid
Published in Swissreg on 21.10.2009
- Oct 31, 2007
Address changed
- Representative
- E. Blum & Co. Patentanwälte, Am Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich
Published in +pat+ No 20 in 2007
- Jul 14, 2006
Agent entered
- Representative
- E. Blum & Co. Patentanwälte, Am Vorderberg 11, 8044 Zürich
Published in +pat+ No 13 in 2006
- Jun 15, 2006
Granted
Published in +pat+ No 11 in 2006
Parties
Inventor
DUNGER, David B., c/o Dept. of Paediatrics
Cambridge CB2 2QQ, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.